First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-21
DOI
10.1007/s10637-020-00924-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
- (2019) Pascal Häfliger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.
- (2019) Angela Lamarca et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study
- (2019) Makoto Ueno et al. Lancet Gastroenterology & Hepatology
- Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
- (2018) Natesh Singh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
- (2018) Travis Salisbury et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance
- (2017) Supak Yothaisong et al. PARASITOLOGY INTERNATIONAL
- Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment
- (2017) Supak Yothaisong et al. TUMOR BIOLOGY
- Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth
- (2016) Y. Cormerais et al. CANCER RESEARCH
- Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells
- (2016) Aaron M. Hosios et al. DEVELOPMENTAL CELL
- Prognostic significance of amino-acid transporter expression (LAT1, ASCT2 and xCT) in surgically resected tongue cancer
- (2014) M Toyoda et al. BRITISH JOURNAL OF CANCER
- Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration
- (2014) Keatdamrong Janpipatkul et al. CELLULAR SIGNALLING
- L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
- (2014) C Rosilio et al. LEUKEMIA
- High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas
- (2014) Nobuyuki Yanagisawa et al. Cancer Medicine
- Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
- (2013) Kyoichi Kaira et al. BMC CANCER
- Investigation of the role of transporters on the hepatic elimination of an LAT1 selective inhibitor JPH203
- (2013) Junko Toyoshima et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
- (2012) K Kaira et al. BRITISH JOURNAL OF CANCER
- Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
- (2011) Mio Furuya et al. CANCER SCIENCE
- Metabolism and Pharmacokinetic Studies of JPH203, an L-Amino Acid Transporter 1 (LAT1) Selective Compound
- (2011) Michael F. Wempe et al. Drug Metabolism and Pharmacokinetics
- High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions
- (2011) Masaaki Ichinoe et al. PATHOLOGY INTERNATIONAL
- Accuracy of various humanNAT2SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes
- (2011) David W Hein et al. PHARMACOGENOMICS
- Arylamine N-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey
- (2011) Audrey Sabbagh et al. PLoS One
- Inhibition of L-Type Amino Acid Transporter Modulates the Expression of Cell Cycle Regulatory Factors in KB Oral Cancer Cells
- (2010) Chun Sung Kim et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
- (2008) K Kaira et al. BRITISH JOURNAL OF CANCER
- Evaluation of thoracic tumors with18F-FMT and18F-FDG PET-CT: A clinicopathological study
- (2008) Kyoichi Kaira et al. INTERNATIONAL JOURNAL OF CANCER
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started